Sign In
Buy LJPC
$6.22
+0 (+0%)
At Close: Jan 27, 2023
Moving Average Crossover Alert: La Jolla Pharmaceutical (LJPC)
07:31am, Tuesday, 18'th May 2021
La Jolla Pharmaceutical (LJPC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
La Jolla Pharmaceutical (LJPC) Misses Q1 Earnings Estimates
11:16am, Friday, 07'th May 2021
La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of -37.31% and 2.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock
WALTHAM, Mass.--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients s
La Jolla Pharmaceutical (LJPC) Reports Q4 Loss, Tops Revenue Estimates
11:22am, Monday, 08'th Mar 2021
La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of 62.86% and 7.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the sto
La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
01:41pm, Monday, 22'nd Feb 2021
La Jolla Pharmaceutical (LJPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
La Jolla Pharma (LJPC) Sees Hammer Chart Pattern: Time to Buy?
09:47am, Wednesday, 23'rd Dec 2020
La Jolla Pharmaceutical Company (LJPC) has been struggling lately, but the selling pressure may be coming to an end soon.
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2020
05:35pm, Monday, 09'th Nov 2020
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffer
Regardless Of Who Wins The White House, This FTSE 100 Stock Could Benefit
12:00am, Wednesday, 14'th Oct 2020
Shares Analysis by Investing.com (Tezcan Gecgil/Investing.com) covering: FTSE 100, CRH PLC, Ashtead Group PLC, Vulcan Materials Company. Read Investing.com (Tezcan Gecgil/Investing.com)'s latest artic
PNC Financial Services Group Inc. Sells 3,271 Shares of Crh Plc (NYSE:CRH)
07:26am, Friday, 02'nd Oct 2020
PNC Financial Services Group Inc. lessened its stake in Crh Plc (NYSE:CRH) by 26.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund
The Global Concrete and Cement Market will grow by USD 332.2 bn during 2020-2024
CRH finance chief announces surprise exit
06:23am, Wednesday, 30'th Sep 2020
Fellow former Bank of Ireland executive Andrew Keating seen as likely successor
Sei Investments Co. Increases Stock Position in Crh Plc (NYSE:CRH)
07:00am, Saturday, 26'th Sep 2020
Sei Investments Co. raised its holdings in Crh Plc (NYSE:CRH) by 33.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutio
Captrust Financial Advisors Invests $63,000 in Crh Plc (NYSE:CRH)
07:46am, Friday, 25'th Sep 2020
Captrust Financial Advisors bought a new stake in Crh Plc (NYSE:CRH) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1
CRH (LON:CRH) Stock Price Crosses Above Two Hundred Day Moving Average of $2,621.96
02:34am, Friday, 25'th Sep 2020
Crh Plc (LON:CRH)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2,621.96 and traded as high as $2,864.00. CRH shares
The Global Wood-plastic Composites Market will grow by USD 3.21 bn during 2020-2024
